Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials.

MLA

Lobo ED, et al. “Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials.” Clinical Pharmacokinetics, vol. 49, no. 5, May 2010, pp. 311–21. EBSCOhost, https://doi.org/10.2165/11319330-000000000-00000.

APA

Lobo ED, Heathman M, Kuan HY, Reddy S, O’Brien L, Gonzales C, Skinner M, Knadler MP, Lobo, E. D., Heathman, M., Kuan, H.-Y., Reddy, S., O’Brien, L., Gonzales, C., Skinner, M., & Knadler, M. P. (2010). Effects of varying degrees of renal impairment on the pharmacokinetics of duloxetine: analysis of a single-dose phase I study and pooled steady-state data from phase II/III trials. Clinical Pharmacokinetics, 49(5), 311–321. https://doi.org/10.2165/11319330-000000000-00000

Chicago

Lobo ED, Heathman M, Kuan HY, Reddy S, O’Brien L, Gonzales C, Skinner M, et al. 2010. “Effects of Varying Degrees of Renal Impairment on the Pharmacokinetics of Duloxetine: Analysis of a Single-Dose Phase I Study and Pooled Steady-State Data from Phase II/III Trials.” Clinical Pharmacokinetics 49 (5): 311–21. doi:10.2165/11319330-000000000-00000.